<article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         dtd-version="1.0"
         article-type="research-article">
   <front>
      <journal-meta>
         <journal-id journal-id-type="jstor">jfinance</journal-id>
         <journal-id journal-id-type="jstor">j100221</journal-id>
         <journal-title-group>
            <journal-title>The Journal of Finance</journal-title>
         </journal-title-group>
         <publisher>
            <publisher-name>Blackwell Publishers</publisher-name>
         </publisher>
         <issn pub-type="ppub">00221082</issn>
         <issn pub-type="epub">15406261</issn>
         <custom-meta-group/>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="jstor">222474</article-id>
         <article-categories>
            <subj-group>
               <subject>Shorter Papers</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title>Contagious Speculation and a Cure for Cancer: A Nonevent That Made Stock Prices Soar</article-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author">
               <string-name>
                  <given-names>Gur</given-names>
                  <surname>Huberman</surname>
               </string-name>
            </contrib>
            <contrib contrib-type="author">
               <string-name>
                  <given-names>Tomer</given-names>
                  <surname>Regev</surname>
               </string-name>
            </contrib>
         </contrib-group>
         <pub-date>
            <day>1</day>
            <month>2</month>
            <year>2001</year>
         </pub-date>
         <volume xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">56</volume>
         <issue xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1</issue>
         <issue-id>i302116</issue-id>
         <fpage>387</fpage>
         <lpage>396</lpage>
         <page-range>387-396</page-range>
         <permissions>
            <copyright-statement>Copyright 2001 American Finance Association</copyright-statement>
         </permissions>
         <self-uri xlink:href="https://www.jstor.org/stable/222474"/>
         <abstract>
            <p>A Sunday New York Times article on a potential development of new cancer-curing drugs caused EntreMed's stock price to rise from 12.063 at the Friday close, to open at 85 and close near 52 on Monday. It closed above 30 in the three following weeks. The enthusiasm spilled over to other biotechnology stocks. The potential breakthrough in cancer research already had been reported, however, in the journal Nature, and in various popular newspapers (including the Times) more than five months earlier. Thus, enthusiastic public attention induced a permanent rise in share prices, even though no genuinely new information had been presented.</p>
         </abstract>
         <custom-meta-group>
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
   </front>
   <back>
      <ref-list>
         <title>References</title>
         <ref id="d71e141a1310">
            <mixed-citation id="d71e145" publication-type="journal">
Abelson, Reed, 1998, Reality punctures Entremed's bubble, New York Times, May 10, 3:6.<person-group>
                  <string-name>
                     <surname>Abelson</surname>
                  </string-name>
               </person-group>
               <issue>May 10</issue>
               <fpage>3</fpage>
               <source>New York Times</source>
               <year>1998</year>
            </mixed-citation>
         </ref>
         <ref id="d71e174a1310">
            <mixed-citation id="d71e178" publication-type="journal">
Boehm, Thomas, Judah Folkman, Timothy Browder, and Michael S. O'Reilly, 1997, Antiangio-
genic therapy of experimental cancer does not induce acquired drug resistance, Nature 390,
404-407.<person-group>
                  <string-name>
                     <surname>Boehm</surname>
                  </string-name>
               </person-group>
               <fpage>404</fpage>
               <volume>390</volume>
               <source>Nature</source>
               <year>1997</year>
            </mixed-citation>
         </ref>
         <ref id="d71e213a1310">
            <mixed-citation id="d71e217" publication-type="journal">
Cook, Robert, 1997, Starving tumors succeeds, Newsday, November 27, A60.<person-group>
                  <string-name>
                     <surname>Cook</surname>
                  </string-name>
               </person-group>
               <issue>November 27</issue>
               <fpage>A60</fpage>
               <source>Newsday</source>
               <year>1997</year>
            </mixed-citation>
         </ref>
         <ref id="d71e246a1310">
            <mixed-citation id="d71e250" publication-type="journal">
Gawande, Atul, 1998, Mouse hunt, New Yorker, May 18, 5-6.<person-group>
                  <string-name>
                     <surname>Gawande</surname>
                  </string-name>
               </person-group>
               <issue>May 18</issue>
               <fpage>5</fpage>
               <source>New Yorker</source>
               <year>1998</year>
            </mixed-citation>
         </ref>
         <ref id="d71e280a1310">
            <mixed-citation id="d71e284" publication-type="journal">
Kerbel, Robert S., 1997, A cancer therapy resistant to resistance, Nature 390, 335-336.<person-group>
                  <string-name>
                     <surname>Kerbel</surname>
                  </string-name>
               </person-group>
               <fpage>335</fpage>
               <volume>390</volume>
               <source>Nature</source>
               <year>1997</year>
            </mixed-citation>
         </ref>
         <ref id="d71e313a1310">
            <mixed-citation id="d71e317" publication-type="journal">
King, Ralph T., 1998, Novel cancer approach from noted scientist hits stumbling block, Wall
Street Journal, November 12, A1.<person-group>
                  <string-name>
                     <surname>King</surname>
                  </string-name>
               </person-group>
               <issue>November 12</issue>
               <fpage>A1</fpage>
               <source>Wall Street Journal</source>
               <year>1998</year>
            </mixed-citation>
         </ref>
         <ref id="d71e349a1310">
            <mixed-citation id="d71e353" publication-type="journal">
Kolata, Gina, 1998, Hope in the lab: A special report; A cautious awe greets drugs that eradi-
cate tumors in mice, New York Times, May 3, 1:1.<person-group>
                  <string-name>
                     <surname>Kolata</surname>
                  </string-name>
               </person-group>
               <issue>May 3</issue>
               <fpage>1</fpage>
               <source>New York Times</source>
               <year>1998</year>
            </mixed-citation>
         </ref>
         <ref id="d71e385a1310">
            <mixed-citation id="d71e389" publication-type="journal">
Wade, Nicholas, 1997, Tests on mice block defense by cancer, New York Times, November 27,
A28<person-group>
                  <string-name>
                     <surname>Wade</surname>
                  </string-name>
               </person-group>
               <issue>November 27</issue>
               <fpage>A28</fpage>
               <source>New York Times</source>
               <year>1997</year>
            </mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
